Trial of a phosphodiesterase 4 inhibitor for idiopathic pulmonary fibrosis. reply.
File(s)nejmc2209529.pdf (301.78 KB)
Published version
Author(s)
Richeldi, Luca
Stowasser, Susanne
Maher, Toby M
Type
Journal Article
Date Issued
2022-08-25
Date Acceptance
2022-08-01
Citation
New England Journal of Medicine, 2022, 387 (8), pp.762-762
ISSN
0028-4793
Publisher
Massachusetts Medical Society
Start Page
762
End Page
762
Journal / Book Title
New England Journal of Medicine
Volume
387
Issue
8
Copyright Statement
© 2022 Massachusetts Medical Society. All rights reserved.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/36001725
PII: 10.1056/NEJMc2209529#sa3
Subjects
Cyclic Nucleotide Phosphodiesterases, Type 4
Humans
Idiopathic Pulmonary Fibrosis
Phosphodiesterase 4 Inhibitors
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2022-08-25